(Teleborsa) - PharmaNutra has archived item the first nine months of 2026 with revenues of sales pairs to 110.9 million, in progress of 17.3% annual. The revenues of the new Business Unit (USA, China, Spain and Cetilar...
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
(Teleborsa) - PharmaNutra has archived item the first nine months of 2026 with revenues of sales pairs to 110.9 million, in progress of 17.3% annual. The revenues of the new Business Unit (USA, China, Spain and Cetilar...